Fungiplex® Aspergillus | Bruker - 雷竞技 lpl夏季赛六支俱乐部赛前变化,雷竞技贴吧

Invasive Aspergillosis

Invasive Aspergillosis(IA) is a life-threatening condition that affects immuno-compromised patients, such as those undergoing hematopoietic stem cell transplantation. Difficult to diagnose, IA is associated with high mortality. Rapid, reliable diagnostic tests forAspergillus, when incorporated into patient care pathways, allow for the targeted use of antifungal therapy.

Clinical problem

Traditional diagnostic techniques, such as culture and histology, have poor clinical sensitivity and tend towards positivity late in disease. Delays in diagnosis by conventional techniques have led to the widespread use of prophylaxis and empiric treatment in the management of IA.

Rapid, reliable diagnostics support physicians in the timely treatment of patients with appropriate therapy, reducing the use of antifungal drugs without adversely affecting patient outcomes.¹, ²

IA is hard to diagnose with non-specific symptoms and poor culture sensitivity.
延误诊断与高mortalit相关联y and morbidity.
The use of prophylaxis and empiric treatment is widespread.

1. Barnes RA et al. 2009 J. Clin. Pathol. 62: 64-60. doi: 10.1136/jcp.2008.058354

2. Morrissey CO et al. 2013 Lancet Infect. Dis. 13: 519-528. doi: 10.1016/S1473-3099(13)70076-8

Características

Molecular testing for Aspergillus

Low sensitivity and slow time to result due to culture methods lead to poor clinical outcomes with traditional methods. Implementing rapid, culture free diagnostic PCR methods improves patient outcomes.

The Fungiplex^®Aspergillus IVD PCR Kit is a real-time PCR designed to detect the main species associated with IA, and differentiates species resistant to first-line treatment:

Aspergillus spp. (A. fumigatus, A. flavus, A. niger)
A. terreus.

Rapid results

The Fungiplex^®Aspergillus IVD PCR Kit provides results in under 2 hours from extracted DNA, helping the laboratory support clinical decision-making when time matters.

The inclusion of real-time PCR in regular biomarker testing strategies for the diagnosis of IA can reduce the time to diagnosis, reduce the use of empiric therapy and ultimately, reduce the cost of care.

Direct Testing

The Fungiplex^®Aspergillus IVD PCR Kit is suitable for the routine testing of patients at risk of IA, and is compatible with samples taken for other biomarker tests:

Validated on DNA extracted from whole blood, serum, plasma
Validated on DNA extracted from bronchoalveolar lavage (BAL) fluid.

Compatibility

The Fungiplex^®Aspergillus IVD PCR Kit is provided in an easy to use master-mix format and is designed to run on existing laboratory equipment, minimizing the need for dedicated bench space or additional training: